Deep Track Capital, LP Geron Corp Call Options Transaction History
Deep Track Capital, LP
- $2.86 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GERN
# of Institutions
302Shares Held
500MCall Options Held
799KPut Options Held
463K-
Ra Capital Management, L.P. Boston, MA60.4MShares$73.1 Million1.99% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$56.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.1MShares$41.3 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$32.9 Million11.75% of portfolio
-
State Street Corp Boston, MA23.9MShares$28.9 Million0.0% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $457M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...